Bottom line
FBTCX vs FBIOX: the short answer
FBTCX (Fidelity Advisor Biotechnology Fund) and FBIOX (Biotechnology Portfolio) are both mutual funds.
FBIOX is cheaper at 0.62% vs 1.69% — a difference of $107 a year per $10,000 invested.
Over five years, FBTCX returned +6.8% a year vs +3.5% for FBIOX (reporting dates differ).
Updated Nov 19, 2026
FBTCX vs FBIOX side by side
| FBTCX | FBIOX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | Fidelity |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 1.69% | 0.62% |
| Annual cost per $10k | $169 | $62 |
| 10-yr cost on $10k (prospectus) | $1,799 | $774 |
| Max front load | — | — |
| 12b-1 fee | 1% | 0% |
| 1-yr return | +37.5% | +36.4% |
| 5-yr return (annualized) | +6.8% | +3.5% |
| 10-yr return (annualized) | +7.7% | +6.9% |
| Best quarter | +30.3% | +33.6% |
| Worst quarter | −27.8% | −28.4% |
| Net assets (fund) | $2.2B | $5.3B |
| Number of holdings | 129 | 215 |
| Portfolio turnover | 54% | 45% |
| Returns as of | Sep 30, 2026 | Apr 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of FBTCX's top 25 holdings also appear in FBIOX's top 25.
| Holding | FBTCX | FBIOX |
|---|---|---|
| Abbvie Inc | 14.71% | 9.22% |
| Gilead Sciences Inc | 5.70% | 4.82% |
| Alnylam Pharmaceuticals Inc | 3.62% | 2.93% |
| Cogent Biosciences Inc | 3.25% | 1.07% |
| Insmed Inc | 3.05% | 2.25% |
| Revolution Medicines Inc | 3.00% | 2.02% |
| Argenx Se | 3.00% | 2.25% |
| Ascendis Pharma A/s | 2.99% | 2.04% |
| Biogen Inc | 2.71% | 1.26% |
| Amgen Inc | 2.37% | 6.53% |
| Fidelity Revere Street Trust | 1.96% | 3.35% |
| Moderna Inc | 1.60% | 1.28% |
| Natera Inc | 1.43% | 1.41% |
Source: SEC Form N-PORT
FBTCX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
FBIOX top 10
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Amgen Inc — 6.53%
- Gilead Sciences Inc — 4.82%
- Fidelity Revere Street Trust — 3.35%
- Alnylam Pharmaceuticals Inc — 2.93%
- Praxis Precision Medicines Inc. — 2.47%
- Insmed Inc — 2.25%
- Argenx Se — 2.25%
- Ascendis Pharma A/s — 2.04%
FAQ
What is the difference between FBTCX and FBIOX?
FBTCX (Fidelity Advisor Biotechnology Fund) and FBIOX (Biotechnology Portfolio) are both mutual funds. FBIOX is cheaper at 0.62% vs 1.69% — a difference of $107 a year per $10,000 invested.
Which is cheaper, FBTCX or FBIOX?
FBIOX has the lower expense ratio (0.62%).
Should I own both FBTCX and FBIOX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.